This report contains important new data about why young people are key to defeating the global HIV/AIDS epidemic, including results from more than 60 new national surveys. It reaffirms that we must accord top priority to making investments in the well-being of young people and to engaging them in the fight against HIV/AIDS.

The number of infants born with HIV infection increases every day. The vast majority of these children are infected through their mothers. Given the vital importance of breastfeeding to a child’s health, and the risk of HIV transmission through breastfeeding, the development of policies on HIV infection and infant feeding is crucial. This document provides policy-makers with key elements for the creation of the aforementioned policies, such as promoting and supporting breastfeeding, improving access to HIV counselling and testing, and preventing commercial pressures for artificial feeding. It also highlights the prevention of HIV infection in women through the promotion of safer sex and the adequate treatment of sexually transmitted infections

This report provides data on the different sources and price ranges of HIV/AIDS drugs. It documents marketing information to help procurement agencies make informed decisions on the source of drugs; manufacturers interested in supplying HIV-related drugs and diagnostics at reduced prices; and the availability and price range of antiretroviral drugs for combination therapy. The report also includes information on essential drugs used to treat a wide range of opportunistic infections, pain-relieving drugs for use in palliative care, and drugs for the treatment of HIV/AIDS-related cancer. For the first time, it provides information on the range of test kits available for the diagnosis of HIV.